Goldman Sachs sees a"slim-upside" to its target for the S&P 500 index this year and gave investors three approaches to navigating an opaque market.
Here are the three strategies Goldman recommended to its clients, as well as some stocks that meet two or more of these criteria. Those stocks include several in health care – Gilead Sciences, Biogen, AbbVie, Amgen – and several smaller companies in the technology sector, such as Amphenol, VeriSign and Lam Research.
"Modest growth means that firms with a low ratio of revenue after variable operating costs to revenue after variable and fixed costs should outperform stocks with a high degree of operating leverage," Goldman said. "Downward pressure on record-high profit margins from labor inflation may prompt negative EPS revisions that are often associated with falling share prices," Goldman said.
In other words: 1. Invest in pharmaceuticals because they rip people off. 2. Invest in technology because it doesn't care about people. 3. Balance low interest rates with loan sharks who rip people off. FinancialLiteracyMonth HumanityFirst
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »